Intro to The Importance of IV Iron in Cardiorenal Anemia Syndrome
IV Iron in CRAS - Core Clinical Concepts
•
2m 18s
A cardiologist, highlights the significance of iron deficiency in cardiorenal anemia syndrome, especially in patients with heart failure and chronic kidney disease. This condition is common in older adults and increases the risk of mortality and morbidity. He advocates for intravenous iron over oral supplements, citing clinical trials that demonstrate its benefits in enhancing exercise capacity and quality of life, supported by recent guidelines.
Up Next in IV Iron in CRAS - Core Clinical Concepts
-
Webinar 1 Characterizing the Patholog...
Cardiorenal Anemia Syndrome (CRAS) involves the complex interplay of heart failure, chronic kidney disease, and anemia. Over 40% of heart failure patients experience CRAS, complicating their management. Anemia worsens both heart failure and chronic kidney disease, with inflammation and hepcidin p...
-
Webinar 2 Deconstructing the Vicious ...
Cardiorenal Anemia syndrome presents a complex challenge, particularly in managing iron deficiency. Effective iron supplementation is crucial, with hepcidin playing a key role in iron homeostasis. Clinical trials show that next-generation IV iron products outperform oral iron in treating heart fa...
-
Webinar 3 An Infusion of Change in th...
The final session on cardiorenal anemia syndrome focuses on treatment strategies to improve patient outcomes. It covers intravenous iron formulations, their dosing, and indications, while emphasizing the importance of recognizing adverse drug reactions. A patient case study highlights the managem...
